Relapse of hepatitis C in three immunocompetent patients achieved a sustained virological response following interferon-based antiviral therapy

被引:0
|
作者
Ji, Fanpu [1 ]
Cai, Zhifang [1 ]
Deng, Hong [1 ]
机构
[1] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Infect Dis, Xian 710049, Peoples R China
关键词
RIBAVIRIN; VIRUS; COMBINATION; DURABILITY;
D O I
10.1016/j.jcv.2013.08.026
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:590 / 591
页数:2
相关论文
共 50 条
  • [1] Depression and Antiviral Response to Interferon-Based Therapy for Hepatitis C Virus Infection
    Loftis, Jennifer M.
    Morasco, Benjamin J.
    Hauser, Peter
    HEPATOLOGY, 2011, 53 (04) : 1413 - 1414
  • [2] Second Hepatectomy for Recurrent Hepatocellular Carcinoma Achieved Sustained Virological Response to Interferon Therapy for Hepatitis C
    Tsujita, Eiji
    Yamashita, Yo-ichi
    Takeishi, Kazuki
    Maeda, Takashi
    Takaki, Shin-ichiro
    Mori, Nami
    Aisaka, Yasuyuki
    Furukawa, Yoshinari
    Shirabe, Ken
    Ishida, Teruyoshi
    Maehara, Yoshihiko
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 2048 - 2054
  • [3] Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12
    Pisaturo, Mariantonietta
    Minichini, Carmine
    Starace, Mario
    Caroprese, Mara
    Macera, Margherita
    Brancaccio, Giuseppina
    De Pascalis, Stefania
    Santonicola, Antonella
    Lanza, Alfonso Galeota
    Zampino, Rosa
    Cotticelli, Gaetano
    Sagnelli, Evangelista
    Gaeta, Giovanni Battista
    Coppola, Nicola
    LIVER INTERNATIONAL, 2019, 39 (05) : 844 - 853
  • [4] Interferon-based therapy of hepatitis C
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (12) : 1222 - 1241
  • [5] Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection
    D'Offizi, Gianpiero
    Camma, Calogero
    Taibi, Chiara
    Schlag, Michael
    Weber, Karin
    Palma, Maria
    De Masi, Ralph
    Janssen, Katrien
    Witek, James
    Lionetti, Raffaella
    NEW MICROBIOLOGICA, 2017, 40 (01) : 19 - 26
  • [6] Racial Differences in Response to Interferon-Based Antiviral Therapy for Hepatitis C Virus Infection: A Hardwiring Issue?
    Tai, Andrew W.
    Chung, Raymond T.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08) : 1101 - 1103
  • [7] Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy Prioritize who needs urgent direct-acting antiviral agents
    Huang, Chao-Min
    Hu, Tsung-Hui
    Chang, Kuo-Chin
    Tseng, Po-Lin
    Lu, Sheng-Nan
    Chen, Chien-Hung
    Wang, Jing-Houng
    Lee, Chuan-Mo
    Tsai, Ming-Chao
    Lin, Ming-Tsung
    Yen, Yi-Hao
    Hung, Chao-Hung
    Cho, Chung-Lung
    Wu, Cheng-Kun
    MEDICINE, 2017, 96 (46)
  • [8] Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients
    Edlich, Birgit
    Ahlenstiel, Golo
    Azpiroz, Aintzane Zabaleta
    Stoltzfus, Jonathan
    Noureddin, Mazen
    Serti, Elisavet
    Feld, Jordan J.
    Liang, T. Jake
    Rotman, Yaron
    Rehermann, Barbara
    HEPATOLOGY, 2012, 55 (01) : 39 - 48
  • [9] Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis
    Ji, Fanpu
    Zhang, Shu
    Deng, Hong
    Li, Zongfang
    JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1262 - 1264
  • [10] Sequence Analysis of Hepatitis C Virus From Patients With Relapse After a Sustained Virological Response: Relapse or Reinfection?
    Hara, Koji
    Rivera, Maria M.
    Koh, Christopher
    DeMino, Mary
    Page, Sandra
    Nagabhyru, Pothu Raju
    Rehermann, Barbara
    Liang, T. Jake
    Hoofnagle, Jay H.
    Heller, Theo
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (01) : 38 - 45